Gunnar Engström1, Olle Melander, Bo Hedblad. 1. Department of Clinical Sciences, Lund University, Malmö University Hospital, Sweden. Gunnar.Engstrom@med.lu.se
Abstract
BACKGROUND: Reduced forced expiratory volume (FEV(1)) and forced vital capacity (FVC) are risk factors for myocardial infarction (MI) and stroke. However, the relationship with incidence of heart failure (HF) is incompletely known. This population-based study explored whether reduced FEV(1) or FVC is associated with the incidence of hospitalisation for HF. METHODS: 20 998 men (mean age 43 years) with no history of MI or stroke were examined with spirometry in 1974-84. The incidence of hospitalisation due to HF was studied over a mean follow-up of 23 years in relation to age- and height-adjusted FEV(1) and FVC. RESULTS: 725 incident HF hospitalisations occurred during the follow-up period, 503 of them without a previous or concurrent diagnosis of MI. In non-smokers the risk factor-adjusted hazard ratio (HR) for HF hospitalisation was 1.25 (95% CI 1.11 to 1.40) and 1.26 (95% CI 1.13 to 1.42), respectively, per 1SD lower FEV(1) and FVC. The corresponding risk factor-adjusted HRs in smokers were 1.32 (95% CI 1.21 to 1.45) and 1.22 (95% CI 1.11 to 1.33), respectively, for FEV(1) and FVC. This relationship was consistent in men with and without hypertension, in men above and below the median age of 44 years and for HF events without previous or concurrent MI. Exclusion of cases with a diagnosis of chronic obstructive pulmonary disease during the follow-up period did not substantially change the results. CONCLUSION: In this long-term population-based study of men, moderately reduced FEV(1) and FVC were associated with an increased incidence of hospitalisations due to HF.
BACKGROUND: Reduced forced expiratory volume (FEV(1)) and forced vital capacity (FVC) are risk factors for myocardial infarction (MI) and stroke. However, the relationship with incidence of heart failure (HF) is incompletely known. This population-based study explored whether reduced FEV(1) or FVC is associated with the incidence of hospitalisation for HF. METHODS: 20 998 men (mean age 43 years) with no history of MI or stroke were examined with spirometry in 1974-84. The incidence of hospitalisation due to HF was studied over a mean follow-up of 23 years in relation to age- and height-adjusted FEV(1) and FVC. RESULTS: 725 incident HF hospitalisations occurred during the follow-up period, 503 of them without a previous or concurrent diagnosis of MI. In non-smokers the risk factor-adjusted hazard ratio (HR) for HF hospitalisation was 1.25 (95% CI 1.11 to 1.40) and 1.26 (95% CI 1.13 to 1.42), respectively, per 1SD lower FEV(1) and FVC. The corresponding risk factor-adjusted HRs in smokers were 1.32 (95% CI 1.21 to 1.45) and 1.22 (95% CI 1.11 to 1.33), respectively, for FEV(1) and FVC. This relationship was consistent in men with and without hypertension, in men above and below the median age of 44 years and for HF events without previous or concurrent MI. Exclusion of cases with a diagnosis of chronic obstructive pulmonary disease during the follow-up period did not substantially change the results. CONCLUSION: In this long-term population-based study of men, moderately reduced FEV(1) and FVC were associated with an increased incidence of hospitalisations due to HF.
Authors: Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2011-04-14 Impact factor: 21.405
Authors: Sunil K Agarwal; Gerardo Heiss; R Graham Barr; Patricia P Chang; Laura R Loehr; Lloyd E Chambless; Eyal Shahar; Dalane W Kitzman; Wayne D Rosamond Journal: Eur J Heart Fail Date: 2012-02-25 Impact factor: 15.534
Authors: Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita Journal: Am J Kidney Dis Date: 2017-07-26 Impact factor: 8.860
Authors: David R Jacobs; Hiroshi Yatsuya; Mary O Hearst; Bharat Thyagarajan; Ravi Kalhan; Sharon Rosenberg; Lewis J Smith; R Graham Barr; Daniel A Duprez Journal: Hypertension Date: 2011-12-27 Impact factor: 10.190
Authors: Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan Journal: Am J Respir Crit Care Med Date: 2018-08-15 Impact factor: 21.405
Authors: Klaus Distelmaier; Alexander Niessner; Dominik Haider; Irene M Lang; Gottfried Heinz; Gerald Maurer; Herbert Koinig; Barbara Steinlechner; Georg Goliasch Journal: Intensive Care Med Date: 2013-04-24 Impact factor: 17.440
Authors: Daniel A Duprez; Mary O Hearst; Pamela L Lutsey; David M Herrington; Pamela Ouyang; R Graham Barr; David A Bluemke; David McAllister; J Jeffrey Carr; David R Jacobs Journal: Hypertension Date: 2013-01-02 Impact factor: 10.190
Authors: Odilson M Silvestre; Wilson Nadruz; Gabriela Querejeta Roca; Brian Claggett; Scott D Solomon; Maria C Mirabelli; Stephanie J London; Laura R Loehr; Amil M Shah Journal: J Am Coll Cardiol Date: 2018-09-04 Impact factor: 24.094